Showing results (31-40 of 78) with videos related to
Sort By:
Pageof 8
International Journal of Radiation Oncology, Biology, Physics|April 11, 2013
Stereotactic ablative body radiation therapy for octogenarians with non-small cell lung cancerAtsuya Takeda, Naoko Sanuki, Takahisa Eriguchi, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 22, 2019
Pleural contact decreases survival in clinical T1N0M0 lung cancer patients undergoing SBRTTakahisa Eriguchi, Atsuya Takeda, Yuichiro Tsurugai, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 6, 2011
The maximum standardized uptake value (SUVmax) on FDG-PET is a strong predictor of local recurrence for localized non-small-cell lung cancer after stereotactic body radiotherapy (SBRT)Atsuya Takeda, Noriko Yokosuka, Toshio Ohashi, et al.International Cancer Conference Journal|May 30, 2023
Symptom palliation with QUAD Shot radiation therapy to penile metastasis derived from descending colon cancer: a case reportAkira Yamamoto, Hideharu Ieki, Mai Shimamura, et al.Radiation Medicine|September 9, 2006
Radiation therapy after breast-conserving surgeryNaoyuki Shigematsu, Atsuya Takeda, Naoko Sanuki, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 6, 2023
Local control correlates with overall survival in radiotherapy for early-stage non-small cell lung cancer: A systematic reviewNaoko Sanuki, Atsuya Takeda, Takahisa Eriguchi, et al.Journal of Radiation Research|May 17, 2014
Feasibility study of stereotactic body radiotherapy for peripheral lung tumors with a maximum dose of 100 Gy in five fractions and a heterogeneous dose distribution in the planning target volumeAtsuya Takeda, Yohei Oku, Naoko Sanuki, et al.Journal of Radiation Research|January 23, 2019
Stereotactic body radiotherapy for patients with non-small-cell lung cancer using RapidArc delivery and a steep dose gradient: prescription of 60% isodose line of maximum dose fitting to the planning target volumeYuichiro Tsurugai, Atsuya Takeda, Naoko Sanuki, et al.Lung Cancer (Amsterdam, Netherlands)|June 5, 2017
Stereotactic body radiotherapy for operable early-stage non-small cell lung cancerTakahisa Eriguchi, Atsuya Takeda, Naoko Sanuki, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 19, 2013
Maximum standardized uptake value on FDG-PET is a strong predictor of overall and disease-free survival for non-small-cell lung cancer patients after stereotactic body radiotherapyAtsuya Takeda, Naoko Sanuki, Hirofumi Fujii, et al.Pageof 8